Clinical Trials Directory

Trials / Completed

CompletedNCT00936312

Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Weill Medical College of Cornell University · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

This is a multi-center, international study designed to collect clinical, genetic and quality of life information on females with hemophilia, an inherited bleeding disorder. The study is designed to determine whether there are problems and issues unique to females with hemophilia.

Detailed description

The study involves two questionnaires: one on the diagnosis, symptoms, complications and treatment of each participant to be completed by a staff member; the other is a questionnaire to be completed by the participant on how the disease has affected her life. Finally, for those participants who have not previously had genetic testing, the third part of the study is an optional blood test to determine the genetic cause, what change in the factor VIII or factor IX gene, caused the hemophilia. The test results will be available to those participants who wish to learn their results. With the data we collect we will compile a database to examine the connection between the genetic cause of hemophilia and the course and symptoms of the disease.

Conditions

Timeline

Start date
2008-03-01
Primary completion
2011-08-01
Completion
2011-08-01
First posted
2009-07-10
Last updated
2012-12-10

Locations

11 sites across 9 countries: United States, Australia, Germany, Israel, Italy, Japan, Netherlands, Sweden, Taiwan

Source: ClinicalTrials.gov record NCT00936312. Inclusion in this directory is not an endorsement.